Mark E Salvati Selected Research

BMS 641988

8/2015	Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.
8/2009	Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark E Salvati Research Topics

Disease

4	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 10/2005
2	Neoplasms (Cancer) 01/2011 - 08/2009
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Kidney Neoplasms (Kidney Cancer) 01/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2011
1	Endometrial Neoplasms (Endometrial Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

3	Androgen Receptors (Androgen Receptor)IBA 04/2011 - 10/2005
2	BMS 641988IBA 08/2015 - 08/2009
2	bicalutamide (Casodex)FDA LinkGeneric 08/2015 - 08/2009
2	Hormones (Hormone)IBA 08/2009 - 10/2005
1	Androgen Receptor AntagonistsIBA 08/2015
1	taxaneIBA 01/2011
1	Dasatinib (BMS 354825)FDA Link 01/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2011
1	Sunitinib (Sutent)FDA Link 01/2011
1	Vorinostat FDA Link 01/2011
1	Lapatinib (GW572016)FDA Link 01/2011
1	AnthracyclinesIBA 01/2011
1	Capecitabine (Xeloda)FDA Link 01/2011
1	Trastuzumab (Herceptin)FDA Link 01/2011
1	Cetuximab (Erbitux)FDA Link 01/2011
1	Bevacizumab (Avastin)FDA Link 01/2011
1	brivanibIBA 01/2011
1	ixabepilone (BMS 247550)FDA Link 01/2011
1	Epirubicin (Ellence)FDA LinkGeneric 01/2011
1	Androgen Antagonists (Antiandrogens)IBA 08/2009
1	Testosterone (Sustanon)FDA Link 10/2005

Therapy/Procedure

2	Therapeutics 01/2011 - 10/2005
1	Aftercare (After-Treatment) 01/2011
1	Drug Therapy (Chemotherapy) 01/2011